Application Sponsors
ANDA 212234 | AJANTA PHARMA LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | EQ 450MG BASE | 0 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-12-26 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2021-06-04 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2021-06-04 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 2022-08-22 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 7 | Null | 15 |
SUPPL | 9 | Null | 15 |
SUPPL | 19 | Null | 7 |
TE Codes
CDER Filings
AJANTA PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 212234
[companyName] => AJANTA PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"EQ 450MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/26\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-12-26
)
)